Literature DB >> 21849806

Platelet-derived growth factor regulates breast cancer progression via β-catenin expression.

Yuhki Yokoyama1, Seiji Mori, Yoshinosuke Hamada, Miki Hieda, Naomasa Kawaguchi, Mohammed Shaker, Yu Tao, Katsuhide Yoshidome, Masahiko Tsujimoto, Nariaki Matsuura.   

Abstract

OBJECTIVE: The knowledge on the association between platelet-derived growth factor (PDGF) signaling and epithelial cancers is scarce, although overexpression of PDGF and PDGF receptors has been reported in some human mesenchymal tumors. Thus, we studied the effect of PDGF on breast cancer cells in vitro and the distribution of PDGF in breast cancer tissues.
METHODS: The effect of PDGF-BB on breast cancer cells was assessed by Western blotting, immunofluorescence, WST and 5-bromo-2-deoxyuridine incorporation experiments. PDGF-B and β-catenin expression was investigated in breast cancer tissues by immunohistochemistry.
RESULTS: PDGF-BB induces β-catenin expression in breast cancer cells, and immunohistochemically the distribution of PDGF-B was similar to β-catenin in breast cancer cells. PDGF-B-positive cancer cells were more frequent in cases of ductal carcinoma in situ (87.5%) than invasive carcinoma (61.2%). In addition, PDGF-B staining was stronger in intraductal than invasive cancer cells. PDGF-BB tended to induce nuclear translocation of β-catenin, cell proliferation and DNA incorporation in MDA-MB231 cells, while these results were not found in MCF-7 cells.
CONCLUSION: Our results suggest that PDGF-BB regulates protein expression of β-catenin and is associated with cancer cell behavior.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849806     DOI: 10.1159/000328061

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  10 in total

1.  Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases.

Authors:  Leandro Marcelo Martinez; Valeria Beatriz Fernández Vallone; Vivian Labovsky; Hosoon Choi; Erica Leonor Hofer; Leonardo Feldman; Raúl Horacio Bordenave; Emilio Batagelj; Federico Dimase; Ana Rodriguez Villafañe; Norma Alejandra Chasseing
Journal:  Clin Exp Metastasis       Date:  2013-10-31       Impact factor: 5.150

Review 2.  Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.

Authors:  Elisa Barone; Federica Gemignani; Stefano Landi
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

3.  Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.

Authors:  Jaime A Espinoza; Shakila Jabeen; Richa Batra; Elena Papaleo; Vilde Haakensen; Vera Timmermans Wielenga; Maj-Lis Møller Talman; Nils Brunner; Anne-Lise Børresen-Dale; Pavel Gromov; Åslaug Helland; Vessela N Kristensen; Irina Gromova
Journal:  Oncoimmunology       Date:  2016-10-24       Impact factor: 8.110

4.  Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer.

Authors:  Rongrong Wu; Shipra Gandhi; Yoshihisa Tokumaru; Mariko Asaoka; Masanori Oshi; Li Yan; Takashi Ishikawa; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2022-07-06       Impact factor: 4.624

5.  Platelet-derived growth factors induced lymphangiogenesis: evidence, unanswered questions and upcoming challenges.

Authors:  Andreea Adriana Jitariu; Anca Maria Cimpean; Nilima Rajpal Kundnani; Marius Raica
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

6.  Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.

Authors:  Roberto Gomez-Casal; Michael W Epperly; Hong Wang; David A Proia; Joel S Greenberger; Vera Levina
Journal:  Oncotarget       Date:  2015-12-29

7.  Robust method for identification of prognostic gene signatures from gene expression profiles.

Authors:  Woogwang Sim; Jungsul Lee; Chulhee Choi
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

8.  Serum Concentration of Selected Angiogenesis-Related Molecules Differs among Molecular Subtypes, Body Mass Index and Menopausal Status in Breast Cancer Patients.

Authors:  Dimitrios Balalis; Dimitrios Tsakogiannis; Eleni Kalogera; Stefania Kokkali; Elli Tripodaki; Alexandros Ardavanis; Dimitrios Manatakis; Dionysios Dimas; Nektarios Koufopoulos; Florentia Fostira; Dimitrios Korkolis; Ioannis Misitzis; Nikolaos Vassos; Chara Spiliopoulou; Dimitrios Vlachodimitropoulos; Garyfalia Bletsa; Nikolaos Arkadopoulos
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

9.  Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes.

Authors:  Roberto Gomez-Casal; Chitralekha Bhattacharya; Nandita Ganesh; Lisa Bailey; Per Basse; Michael Gibson; Michael Epperly; Vera Levina
Journal:  Mol Cancer       Date:  2013-08-16       Impact factor: 27.401

10.  The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.

Authors:  Marlene Heckl; Elisa Schmoeckel; Linda Hertlein; Miriam Rottmann; Udo Jeschke; Doris Mayr
Journal:  PLoS One       Date:  2018-02-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.